ethambutol has been researched along with chloroquine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Cedillo-Rivera, R; Chan-Bacab, MJ; Estrada-Soto, S; Guerrero-Alvarez, J; León-Rivera, I; Mirón-López, G; Molina-Salinas, GM; Moo-Puc, R; Nava-Zuazo, C; Navarrete-Vazquez, G; Said-Fernández, S | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Bharate, SB; Khan, IA; Khan, SI; Singh, S; Vishwakarma, RA; Yadav, RR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Jaeger, W | 1 |
| Babel, J; Korol, S; Meyer, JJ | 1 |
| François, J | 1 |
| Van Lith, GH | 1 |
| Barg, TsM | 1 |
| Futenma, M | 1 |
| Bornstein, Y; Käppeli, F | 1 |
| Jackson, EA; McLeod, DC | 1 |
| Motegi, T | 1 |
| Lanneluc, C; Le Rebeller, MJ; Lotte, C | 1 |
| Ikebe, T; Ikewaki, J; Imaizumi, M; Nakatsuka, K | 1 |
3 review(s) available for ethambutol and chloroquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Eye complications during use of various medicinal substances with general effects (review of the literature)].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Allopurinol; Anti-Bacterial Agents; Antimalarials; Cardiac Glycosides; Cataract; Child; Chloroquine; Chlorpromazine; Epinephrine; Ethambutol; Ethchlorvynol; Eye Diseases; Female; Humans; Miotics; Nalidixic Acid; Phosphates; Pilocarpine; Quinolines; Retinal Degeneration; Warfarin | 1969 |
[Drug-induced visual disturbance].
Topics: Amiodarone; Anti-Asthmatic Agents; Antimalarials; Antitubercular Agents; Antiviral Agents; Chloroquine; Chlorpromazine; Dopamine Antagonists; Ethambutol; Eye Diseases; Glucocorticoids; Humans; Interferons; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2007 |
17 other study(ies) available for ethambutol and chloroquine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Design, synthesis, and in vitro antiprotozoal, antimycobacterial activities of N-{2-[(7-chloroquinolin-4-yl)amino]ethyl}ureas.
Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Drug Design; Giardia lamblia; Humans; Leishmania mexicana; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Urea | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis, antimalarial and antitubercular activities of meridianin derivatives.
Topics: Animals; Antimalarials; Antitubercular Agents; Cell Line, Tumor; Humans; Indoles; Inhibitory Concentration 50; Plasmodium falciparum; Pyrimidines; Quantitative Structure-Activity Relationship; Sulfonamides | 2015 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Acquired colour-vision-deficiencies caused by side-effects of pharmacotherapy (author's transl)].
Topics: Antipsychotic Agents; Chloramphenicol; Chloroquine; Chlorpropamide; Color Vision Defects; Contraceptives, Oral; Digitoxin; Ethambutol; Humans; Indomethacin; Monoamine Oxidase Inhibitors; Optic Neuritis; Phenothiazines; Retinal Diseases; Sparsomycin | 1977 |
[Functional exploration of the perimacular and macular retinal region by means of flicker E.R.G. and the determination of perceptive fusion thresholds of an intermittent light (De Lange's curve)].
Topics: Adult; Chloroquine; Electroretinography; Ethambutol; Flicker Fusion; Humans; Macula Lutea; Methods; Photic Stimulation; Retina; Retinal Degeneration; Retinal Diseases; Visual Acuity | 1975 |
[Toxic retinopathies].
Topics: Chloroquine; Copper; Digitalis Glycosides; Epinephrine; Ethambutol; Humans; Immunosuppressive Agents; Indomethacin; Lysergic Acid Diethylamide; Ophthalmic Solutions; Phenothiazines; Quinine; Retinal Diseases; Siderosis | 1979 |
Electro-ophthalmology and side-effects of drugs.
Topics: Chloroquine; Diagnosis, Differential; Electrooculography; Ethambutol; Eye Diseases; Humans; Iatrogenic Disease | 1977 |
[Chloroquine and ethambutol oculopathies in Japan].
Topics: Chloroquine; Ethambutol; Female; Humans; Japan; Male; Retinal Diseases; Vision Disorders | 1974 |
[Ocular adverse effects of generally used drugs].
Topics: Chloroquine; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Eye Diseases; Humans; Indomethacin | 1973 |
Pharmacokinetics and dosing of antimicrobial agents in renal impairment, Part II.
Topics: Anti-Infective Agents; Bacitracin; Chloramphenicol; Chloroquine; Clindamycin; Dapsone; Ethambutol; Humans; Isoniazid; Kidney Diseases; Methenamine; Nalidixic Acid; Neomycin; Nitrofurantoin; Sulfadimethoxine; Sulfamethizole; Sulfamethoxazole; Sulfamethoxypyridazine; Sulfisomidine; Sulfisoxazole; Vancomycin | 1974 |
[Eye diseases induced by ethambutol].
Topics: Adult; Aged; Chloroquine; Ethambutol; Eye Diseases; Female; Humans; Iatrogenic Disease; Male; Middle Aged; Vision Disorders | 1969 |
[Monitoring and prevention of iatrogenic ocular effect in general therapy].
Topics: Adult; Aged; Antimalarials; Chloroquine; Ethambutol; Eye Diseases; Humans; Male; Middle Aged; Scotoma; Visual Acuity; Visual Field Tests; Visual Fields | 1981 |